• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 4CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 4CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-180
Medical Device Problem Code False Negative Result (1225)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/21/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
 
Event or Problem Description
The consumer reported a false negative result with the binaxnow covid-19 ag self-test performed on (b)(6) 2025 with a nasal sample.A previous test (access bio care start) was performed on (b)(6) 2025 and generated positive results.Although requested, no additional information was provided, including details about the treatment and the outcome.
 
Additional Manufacturer Narrative
Additional information: d2b - procode.G4 - pma/510(k).Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 000905512a with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 195-180/ lot 000905512a, test base part number 195-430wjr/ lot 905512.The lot met the required release specifications.A review of the complaints reported as false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 000905512 showed that the complaint rate is (b)(4).Abbott diagnostics scarborough, inc.Was unable to determine the exact root cause of the reported issue, however it could have possibly been related to the specific patient sample.
 
Event or Problem Description
The consumer reported a false negative result with the binaxnow covid-19 ag self-test performed on (b)(6) 2025 with a nasal sample.A previous test (access bio care start) was performed on (b)(6) 2025 and generated positive results.Although requested, no additional information was provided, including details about the treatment and the outcome.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 4CT
Common Device Name
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key21264672
Report Number1221359-2025-00025
Device Sequence Number18508726
Product Code QYT
UDI-Device Identifier00811877011729
UDI-Public01008118770117291726061410000905512A
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K243518
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 04/17/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date06/14/2026
Device Catalogue Number195-180
Device Lot Number000905512A
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/21/2025
Supplement Date Received by Manufacturer04/15/2025
Initial Report FDA Received Date01/29/2025
Supplement Report FDA Received Date04/17/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/23/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexFemale
-
-